NEW YORK, Feb. 23, 2018 -- Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of Xunlei Limited (NASDAQ:XNET) from October 10, 2017 through January 11, 2018, both dates inclusive (“Class Period”). The lawsuit seeks to recover damages for Xunlei investors under the federal securities laws.
To join the Xunlei class action, go to http://www.rosenlegal.com/cases-1276.html or call Phillip Kim, Esq. or Daniel Sadeh, Esq. toll-free at 866-767-3653 or email [email protected] or [email protected] for information on the class action.
NO CLASS HAS YET BEEN CERTIFIED IN THE ABOVE ACTION. UNTIL A CLASS IS CERTIFIED, YOU ARE NOT REPRESENTED BY COUNSEL UNLESS YOU RETAIN ONE. YOU MAY ALSO REMAIN AN ABSENT CLASS MEMBER AND DO NOTHING AT THIS POINT. YOU MAY RETAIN COUNSEL OF YOUR CHOICE.
According to the lawsuit, defendants during the Class Period made materially false and/or misleading statements and/or failed to disclose that: (1) Xunlei had engaged in unlawful financial activity; (2) OneCoin, Xunlei’s blockchain-based product, was a form of disguised Initial Coin Offering; (3) Xunlei was engaged in the promotion of an Initial Miner Offering; and (4) as a result, defendants’ statements about Xunlei’s business, operations, and prospects were false and misleading and/or lacked a reasonable basis. When the true details entered the market, the lawsuit claims that investors suffered damages.
A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than March 20, 2018. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. If you wish to join the litigation, go to http://www.rosenlegal.com/cases-1276.html or to discuss your rights or interests regarding this class action, please contact Phillip Kim or Daniel Sadeh of Rosen Law Firm toll free at 866-767-3653 or via email at [email protected] or [email protected].
Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm or on Twitter: https://twitter.com/rosen_firm.
Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Since 2014, Rosen Law Firm has been ranked #2 in the nation by Institutional Shareholder Services for the number of securities class action settlements annually obtained for investors. Attorney Advertising. Prior results do not guarantee a similar outcome.
| Contact Information: |
| Laurence Rosen, Esq. Phillip Kim, Esq. Daniel Sadeh, Esq. The Rosen Law Firm, P.A. 275 Madison Avenue, 34th Floor New York, NY 10016 Tel: (212) 686-1060 Toll Free: (866) 767-3653 Fax: (212) 202-3827 [email protected] [email protected] [email protected] www.rosenlegal.com |


Alphabet Stock Slides as Google AI Pioneer Jeff Dean Exits to Launch Discovery Loop
Daimler Truck Q2 Profit Falls 18%, 2026 Outlook Raised
Sinopec Boosts Russian ESPO Oil Purchases as Middle East Supply Tightens
Glencore Posts Strong H1 2026 Earnings, Announces ASX Secondary Listing
DoorDash Q2 Revenue Jumps 36% as Orders and DashPass Growth Drive Results
DBS Raises 2025 Outlook After Record Q2 Profit Driven by Wealth Management
Nvidia Seen Beating Q2 Targets as Vera Rubin Cycle Begins
Cloudflare Stock Jumps 15% as Earnings Beat Estimates, 2026 Outlook Raised
DeepSeek to Raise AI API Prices as Demand for New Models Surges
Alibaba Plans Revenue-Sharing Model for Qwen3.8-Max AI Commercial Users
Delta Flight Makes Emergency Landing in Atlanta After Cockpit Fumes Reported
Treasury Wine Estates Shares Jump as U.S. Overhaul Lifts FY2026 Outlook
AMP Shares Surge 13% After Strong Profit and A$150 Million Buyback
Nintendo Shares Jump as Switch 2 Sales Boost Earnings
UOB Q2 Net Profit Rises 10% as Wealth Management Growth Boosts Earnings
Meta AI Model Exploits Security Flaw During Cybersecurity Test, Raising AI Safety Concerns
Moderna Wins FDA Approval for mFLUSIVA mRNA Flu Vaccine for Adults 50+ 



